These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4344217)

  • 1. Antibodies to surface antigens of herpesvirus type 1- and type 2-infected cells among women with cervical cancer and control women.
    Smith JW; Lowry SP; Melnick JL; Rawls WE
    Infect Immun; 1972 Mar; 5(3):305-10. PubMed ID: 4344217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
    Aurelian L; Strandberg JD; Marcus RL
    Prog Exp Tumor Res; 1974; 19():165-81. PubMed ID: 4612606
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative complement fixation and serum neutralization antibody titers to herpes simplex virus type 1 and Herpesvirus simiae in Macaca mulatta and humans.
    Gary GW; Palmer EL
    J Clin Microbiol; 1977 Apr; 5(4):465-70. PubMed ID: 192762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera.
    Hollinshead A; Lee OB; McKelway W; Melnick JL; Rawls WE
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):688-93. PubMed ID: 4564620
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to herpesvirus type 1 and type 2 among Japanese cervical cancer patients.
    Ozaki Y; Ishiguro T; Ohashi M; Sawaragi I; Ito Y
    Gan; 1978 Feb; 69(1):119-22. PubMed ID: 640320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of IgA antibody to herpesvirus in cervicovaginal secretions of patients with carcinoma of the cervix.
    Dent PB; Bienenstock J
    Clin Immunol Immunopathol; 1974 Nov; 3(2):171-7. PubMed ID: 4615850
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma.
    Aurelian L; Schumann B; Marcus RL; Davis HJ
    Science; 1973 Jul; 181(4095):161-4. PubMed ID: 4711734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
    Kawana T; Cornish JD; Smith MF; Aurelian L
    Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to herpesviruses in patients with cervical cancer and controls.
    Muñoz N; de-Thé G; Aristizabal N; Yee C; Rabson A; Pearson G
    IARC Sci Publ (1971); 1975; (11 Pt 2):45-51. PubMed ID: 191382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibodies to herpesvirus early antigens in patients with cervical carcinoma determined by anticomplement immunofluorescence technique.
    Ito H; Tsutsui F; Kurihara S; Akabayashi T; Tobe T
    Int J Cancer; 1976 Nov; 18(5):557-63. PubMed ID: 62718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to herpesvirus nonvirion antigens in squamous carcinomas.
    Hollinshead AC; Lee O; Chretien PB; Tarpley JL; Rawls WE; Adam E
    Science; 1973 Nov; 182(4113):713-5. PubMed ID: 4752210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes type-2 virus antigens in human cervical carcinoma.
    Adelusi B; Osunkoya BO; Fabiyi A
    Obstet Gynecol; 1976 May; 47(5):545-8. PubMed ID: 772507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble membrane antigens of lip and cervical carcinomas: reactivity with antibody for herpesvirus nonvirion antigens.
    Hollinshead AC; Tarro G
    Science; 1973 Feb; 179(4074):698-700. PubMed ID: 4734354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls.
    Pacsa AS; Kummerländer L; Pejtsik B; Pali K
    J Natl Cancer Inst; 1975 Oct; 55(4):775-81. PubMed ID: 171424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological evidence for variation in the incidence of herpesvirus infections in different species of apes.
    Eberle R; Hilliard JK
    J Clin Microbiol; 1989 Jun; 27(6):1357-66. PubMed ID: 2546978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to herpesvirus type 2 in breast cancer and cervical cancer patients.
    Adam E; Sanders EK; Melnick JL; Levy AH; Rawls WE
    Cancer; 1974 Jan; 33(1):147-52. PubMed ID: 4810088
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency of anti-AG-4 antibody in patients with uterine cervical cancer and controls.
    Kawana T; Sakamoto S; Kasamatsu T; Aurelian L
    Gan; 1978 Aug; 69(4):589-91. PubMed ID: 710808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
    Jankowski MA; Petersen EE; Böcker JF
    Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSV-2 antigens absent from biopsied cervical tumor cells: a model consistent with latency.
    Aurelian L; Strandberg JD; Davis HJ
    Proc Soc Exp Biol Med; 1972 Jun; 140(2):404-8. PubMed ID: 4556658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.